Effect of Fra-2 expression on tumour immunogenicity and prognosis in KRAS-mutant lung adenocarcinoma

被引：0
|
作者：
Ucero, A. C. [1 ]
Gutierrez Perez, M. [1 ]
Zazo, A. [1 ]
Bakiri, L. [2 ,3 ]
Wagner, E. F. [2 ,3 ]
Paz-Ares, L. [1 ]
机构：
[1] Univ Complutense, Hosp Univ 12 Octubre, Translat Oncol & Lung Canc Unit,Physiol & Med Dep, CNIO H12o Lung Canc Unit & Ciberonc, Madrid, Spain
[2] Med Univ Vienna, Dept Lab Med, Inst Canc Res, Vienna, Austria
[3] Med Univ Vienna, Dept Dermatol, Inst Canc Res, Vienna, Austria
来源：
ANNALS OF ONCOLOGY | 2023年 / 34卷
关键词：
D O I：
10.1016/j.annonc.2023.09.759
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1281P
引用
收藏
页码：S740 / S740
页数：1
相关论文
共 50 条
  • [41] Identification of LGR4 as a prognostic biomarker in KRAS-mutant lung adenocarcinoma: Evidence from integrated bioinformatics analysis
    Dodin, Yasmeen
    MEDICINE, 2023, 102 (46) : E36084
  • [42] An emerging role for inflammation- associated alveolar intermediate cells in early phenotypic development of KRAS-mutant lung adenocarcinoma
    Sinjab, Ansam
    Han, Guangchun
    Treekitkarnmongkol, Warapen
    Hao, Dapeng
    Dai, Enyu
    Solis, Luisa M.
    Moghaddam, Seyed Javad
    Fujimoto, Junya
    Chen, Jichao
    Edwards, Matthew
    Stevenson, Christopher S.
    Spira, Avrum E.
    Wang, Linghua
    Kadara, Humam
    CANCER RESEARCH, 2022, 82 (12)
  • [43] FOXA2 Promotes the Growth of KRAS-Mutant Lung Tumors but Suppresses the Growth of EGFR-Mutant Lung Tumors in Vivo
    Tomoshige, K.
    Stuart, W.
    Fink-Baldauf, I.
    Maeda, Y.
    JOURNAL OF THORACIC ONCOLOGY, 2020, 15 (02) : S31 - S31
  • [44] PPP2R4 dysfunction promotes KRAS-mutant lung adenocarcinoma development and mediates opposite responses to MEK and mTOR inhibition
    Meeusen, Bob
    Cortesi, Emanuela Elsa
    Omella, Judit Domenech
    Sablina, Anna
    Ventura, Juan-Jose
    Janssens, Veerle
    CANCER LETTERS, 2021, 520 : 57 - 67
  • [45] Impact of Kras mutant subtypes on PD-L1 expression in lung adenocarcinoma
    Ilie, Marius
    Fazzalari, Laetitia
    Guibert, Nicolas
    Yazbeck., Nathalie
    Signetti, Laurie
    Hofman, Veronique
    Long, Elodie
    Zahaf, Katia
    Fayada, Julien
    Lespinet, Virginie
    Bordone, Olivier
    Tanga, Virginie
    Washetine, Kevin
    Venissac, Nicolas
    Mouroux, Jerome
    Marquette, Charles Hugo
    Brest, Patrick
    Hofnnan, Paul
    CANCER RESEARCH, 2016, 76
  • [46] Impact of Kras mutant subtypes on PD-L1 expression in lung adenocarcinoma
    Falk, A.
    Yazbeck, N.
    Thon, L.
    Hofman, V.
    Zahaf, K.
    Washetine, K.
    Cohen, C.
    Marquette, C. H.
    Brest, P.
    Llie, M.
    Holman, P.
    VIRCHOWS ARCHIV, 2016, 469 : S40 - S40
  • [47] Impact of Kras mutant subtypes on PD-L1 expression in lung adenocarcinoma
    Falk, A. T.
    Yazbeck, N.
    Thon, L.
    Guibert, N.
    Hofman, V.
    Zahaf, K.
    Lespinet, V.
    Bordone, O.
    Tanga, V.
    Washetine, K.
    Cohen, C.
    Venissac, N.
    Mouroux, J.
    Marquette, C-H.
    Brest, P.
    Ilie, M.
    Hofman, P.
    ANNALS OF ONCOLOGY, 2016, 27
  • [48] Small Cell Lung Cancer Transformation as a Mechanism of Resistance to PD-1 Therapy in KRAS-Mutant Lung Adenocarcinoma: A Report of Two Cases
    Iams, Wade T.
    Beckermann, Kathryn E.
    Almodovar, Karinna
    Hernandez, Jennifer
    Vnencak-Jones, Cindy
    Lim, Lee P.
    Raymond, Christopher K.
    Horn, Leora
    Lovly, Christine M.
    JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (03) : E45 - E48
  • [49] High mesothelin expression in advanced lung adenocarcinoma is associated with KRAS mutations and a poor prognosis
    Thomas, Anish
    Chen, Yuanbin
    Steinberg, Seth M.
    Luo, Ji
    Pack, Svetlana
    Raffeld, Mark
    Abdullaev, Zied
    Alewine, Christine
    Rajan, Arun
    Giaccone, Giuseppe
    Pastan, Ira
    Miettinen, Markku
    Hassan, Raffit
    ONCOTARGET, 2015, 6 (13) : 11694 - 11702
  • [50] STK11/LKB1 Mutations and PD-1 Inhibitor Resistance in KRAS-Mutant Lung Adenocarcinoma
    Skoulidis, Ferdinandos
    Goldberg, Michael E.
    Greenawalt, Danielle M.
    Hellmann, Matthew D.
    Awad, Mark M.
    Gainor, Justin F.
    Schrock, Alexa B.
    Hartmaier, Ryan J.
    Trabucco, Sally E.
    Gay, Laurie
    Ali, Siraj M.
    Elvin, Julia A.
    Singal, Gaurav
    Ross, Jeffrey S.
    Fabrizio, David
    Szabo, Peter M.
    Chang, Han
    Sasson, Ariella
    Srinivasan, Sujaya
    Kirov, Stefan
    Szustakowski, Joseph
    Vitazka, Patrik
    Edwards, Robin
    Bufill, Jose A.
    Sharma, Neelesh
    Ou, Sai-Hong I.
    Peled, Nir
    Spigel, David R.
    Rizvi, Hira
    Aguilar, Elizabeth Jimenez
    Carter, Brett W.
    Erasmus, Jeremy
    Halpenny, Darragh F.
    Plodkowski, Andrew J.
    Long, Niamh M.
    Nishino, Mizuki
    Denning, Warren L.
    Galan-Cobo, Ana
    Hamdi, Haifa
    Hirz, Taghreed
    Tong, Pan
    Wang, Jing
    Rodriguez-Canales, Jaime
    Villalobos, Pamela A.
    Parra, Edwin R.
    Kalhor, Neda
    Sholl, Lynette M.
    Sauter, Jennifer L.
    Jungbluth, Achim A.
    Mino-Kenudson, Mari
    CANCER DISCOVERY, 2018, 8 (07) : 822 - 835
12345